Search results
ESC 2025 Hot Line & Late-Breaking Science Collection
Video Series
Author(s):
Milind Y Desai
Added:
1 year ago
AHA Conference 2024 - 22 month data from the risk evaluation and mitigation strategy (REMS) program for mavacamten (Camzyos; Bristol-Myers Squibb Company) in hypertrophic cardiomyopathy (HCM) patients.Dr Milind Desai (Cleveland Clinic, Ohio, US) joins us onsite at AHA Conference to discuss the findings from the REMS program for mavacamten.The REMS program investigated the safety and efficacy of…
View more
Daniele Andreini
Research Area(s) / Expertise:
Author
José Carlos Romero Carmona
Author
Jihad Mustapha
Job title: Co-founder and CEO
Author
Nita Ray Chaudhuri
Job title: Director of the Pediatric Cardiac CT/MRI Program
Author
Mintu Turakhia
Job title: Cardiac Electrophysiologist
Author
Josef Kautzner
Research Area(s) / Expertise:
Job title: Professor of Medicine
Author
Patrick Nataf
Job title: Professor of Surgery and Head of the Department of Cardiac Surgery
Author
Oliver Monfredi
Author